Archive for the ‘Market-Health Care’ Category

Merck Advances BACE Inhibitor Trial for Alzheimer’s Disease

16th January 2014 by Christian Elliott Comments Off

Merck announced last month that it is moving ahead with MK-8931, an experimental BACE inhibitor drug designed to slow the production of amyloid beta protein in the brain, one of the hallmarks of Alzheimer’s disease. Beta secretase (BACE) inhibitors work by interfering with the process that creates amyloid beta protein in the first place, in […]

    High Blood Pressure and Cognitive Decline

    10th October 2013 by Christian Elliott Comments Off

    More confirmation that high blood pressure (hypertension) directly impacts brain health from this study in the British Medical Journal. The BMJ study followed over 5,000 older adults (average age of 75) for three years, measuring both blood pressure and cognitive health during medical visits performed four times a year. The researchers found a consistent pattern […]

      Brain Health and Wellness Apps

      3rd October 2013 by Christian Elliott Comments Off

      The Health 2.0 Conference in Silicon Valley this week provided a forward-looking view on what health care could look like in the next several years. Many of the themes revolved around real time (and personalized) health monitoring, and the growing ability for people to take control of their own health care choices. There are a […]

        Using Blood Protein Markers for Brain Health Screening

        6th August 2013 by Christian Elliott Comments Off

        Can a simple blood test be possible to screen for Alzheimer’s disease and other brain conditions? New research discussed at the Alzheimer’s Association International Conference (AAIC) last month suggests that reliable, low cost blood serum analysis for brain biomarkers is a possibility within the next decade or so. Blood tests are an attractive screening option […]

          Should Medicare Cover the Cost of Brain Imaging Tests for Alzheimer’s Diagnosis?

          16th July 2013 by Christian Elliott Comments Off

          I’m at the Alzheimer’s Association International Conference (AAIC) in Boston this week, and one of the most discussed topics is the power of brain imaging tests to detect amyloid beta protein in the brain, one of the main hallmarks of Alzheimer’s disease pathology. Positron Emission Tomography (PET) imaging tests can identify amyloid beta deposits in […]